Mary A Gerend1, Yesenia P Stephens2, Michelle M Kazmer3, Elizabeth H Slate4, Elena Reyes5. 1. Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University (FSU), Tallahassee, Florida. Electronic address: mary.gerend@med.fsu.edu. 2. College of Medicine, Florida State University, Tallahassee, Florida. 3. School of Information, College of Communication and Information, Florida State University, Tallahassee, Florida. 4. Department of Statistics, College of Arts & Sciences, Florida State University, Tallahassee, Florida. 5. Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University (FSU), Tallahassee, Florida.
Abstract
PURPOSE: The purpose of this longitudinal study was to identify individual and interpersonal factors associated with human papillomavirus (HPV) vaccine series completion in a sample of low-income Latina/o adolescent girls and boys. METHODS: Caregiver-adolescent dyads (N = 161) were recruited from a rural Federally Qualified Health Center in southwest Florida when the adolescent (aged 11-17 years) received the first dose of HPV vaccine. Dyads completed a baseline assessment that measured demographic and cultural characteristics, past medical history, provider-patient communication, HPV knowledge, health beliefs about completing the series, and the adolescent's experience receiving the first dose. Using multivariable logistic regression, we identified caregiver- and adolescent-related factors associated with series completion (receipt of three doses of HPV vaccine within 1 year of initiation) as indicated in the adolescent's medical record and state immunization registry. RESULTS: Within 1 year of initiation, 57% (n = 92) completed the three-dose series. Missed opportunities for completion were observed for 20% of the sample who returned to the clinic. Caregiver-related predictors of completion included education, self-efficacy to complete the series, and knowledge of the required number of doses. Adolescent-related predictors included age, influenza vaccination within the past 2 years, having a chronic medical condition, reason for the baseline visit, and receipt of written information about HPV vaccination from a health care provider. CONCLUSIONS: Findings highlight important opportunities for improving completion of the HPV vaccine series among Latina/o adolescents. Intervention efforts should involve health care providers and parent-adolescent dyads and prioritize evidence-based strategies for reducing missed opportunities for series completion.
PURPOSE: The purpose of this longitudinal study was to identify individual and interpersonal factors associated with human papillomavirus (HPV) vaccine series completion in a sample of low-income Latina/o adolescent girls and boys. METHODS: Caregiver-adolescent dyads (N = 161) were recruited from a rural Federally Qualified Health Center in southwest Florida when the adolescent (aged 11-17 years) received the first dose of HPV vaccine. Dyads completed a baseline assessment that measured demographic and cultural characteristics, past medical history, provider-patient communication, HPV knowledge, health beliefs about completing the series, and the adolescent's experience receiving the first dose. Using multivariable logistic regression, we identified caregiver- and adolescent-related factors associated with series completion (receipt of three doses of HPV vaccine within 1 year of initiation) as indicated in the adolescent's medical record and state immunization registry. RESULTS: Within 1 year of initiation, 57% (n = 92) completed the three-dose series. Missed opportunities for completion were observed for 20% of the sample who returned to the clinic. Caregiver-related predictors of completion included education, self-efficacy to complete the series, and knowledge of the required number of doses. Adolescent-related predictors included age, influenza vaccination within the past 2 years, having a chronic medical condition, reason for the baseline visit, and receipt of written information about HPV vaccination from a health care provider. CONCLUSIONS: Findings highlight important opportunities for improving completion of the HPV vaccine series among Latina/o adolescents. Intervention efforts should involve health care providers and parent-adolescent dyads and prioritize evidence-based strategies for reducing missed opportunities for series completion.
Authors: Tara P L Neubrand; Carmen Radecki Breitkopf; Richard Rupp; Daniel Breitkopf; Susan L Rosenthal Journal: Clin Pediatr (Phila) Date: 2009-05-29 Impact factor: 1.168
Authors: Tanya L Kowalczyk Mullins; Gregory D Zimet; Susan L Rosenthal; Charlene Morrow; Lili Ding; Marcia Shew; J Dennis Fortenberry; David I Bernstein; Jessica A Kahn Journal: Arch Pediatr Adolesc Med Date: 2012-01
Authors: Betty Chou; Lauren S Krill; Bernice B Horton; Christopher E Barat; Cornelia L Trimble Journal: Obstet Gynecol Date: 2011-07 Impact factor: 7.661
Authors: Lea E Widdice; David I Bernstein; Anthony C Leonard; Keith A Marsolo; Jessica A Kahn Journal: Pediatrics Date: 2010-12-13 Impact factor: 7.124
Authors: Stephanie A S Staras; Eric Richardson; Lisa J Merlo; Jiang Bian; Lindsay A Thompson; Janice L Krieger; Matthew J Gurka; Ashley H Sanders; Elizabeth A Shenkman Journal: BMC Public Health Date: 2021-01-09 Impact factor: 3.295
Authors: Matthew Asare; Peter Agyei-Baffour; Beth A Lanning; Alex Barimah Owusu; Mary E Commeh; Kathileen Boozer; Adofo Koranteng; Lori A Spies; Jane R Montealegre; Electra D Paskett Journal: Int J Environ Res Public Health Date: 2020-01-16 Impact factor: 3.390